Natures Sunshine Products Inc (NATR) - Net Assets
Based on the latest financial reports, Natures Sunshine Products Inc (NATR) has net assets worth $166.92 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($261.46 Million) and total liabilities ($94.54 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Natures Sunshine Products Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $166.92 Million |
| % of Total Assets | 63.84% |
| Annual Growth Rate | 8.13% |
| 5-Year Change | 0.09% |
| 10-Year Change | 22.02% |
| Growth Volatility | 15.14 |
Natures Sunshine Products Inc - Net Assets Trend (1985–2025)
This chart illustrates how Natures Sunshine Products Inc's net assets have evolved over time, based on quarterly financial data. See Natures Sunshine Products Inc (NATR) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Natures Sunshine Products Inc (1985–2025)
The table below shows the annual net assets of Natures Sunshine Products Inc from 1985 to 2025. For live valuation and market cap data, see how much is Natures Sunshine Products Inc worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $161.55 Million | +0.35% |
| 2024-12-31 | $160.99 Million | +0.91% |
| 2023-12-31 | $159.54 Million | +8.50% |
| 2022-12-31 | $147.05 Million | -8.90% |
| 2021-12-31 | $161.40 Million | +2.65% |
| 2020-12-31 | $157.23 Million | +21.48% |
| 2019-12-31 | $129.44 Million | +7.36% |
| 2018-12-31 | $120.57 Million | +0.70% |
| 2017-12-31 | $119.73 Million | -9.57% |
| 2016-12-31 | $132.40 Million | -2.84% |
| 2015-12-31 | $136.26 Million | +5.67% |
| 2014-12-31 | $128.96 Million | +22.51% |
| 2013-12-31 | $105.26 Million | -8.97% |
| 2012-12-31 | $115.64 Million | +32.25% |
| 2011-12-31 | $87.44 Million | +27.87% |
| 2010-12-31 | $68.38 Million | +19.77% |
| 2009-12-31 | $57.09 Million | +6.37% |
| 2008-12-31 | $53.68 Million | -11.12% |
| 2007-12-31 | $60.39 Million | -11.43% |
| 2006-12-31 | $68.19 Million | -9.58% |
| 2005-12-31 | $75.41 Million | -17.33% |
| 2004-12-31 | $91.22 Million | +17.94% |
| 2003-12-31 | $77.34 Million | -7.82% |
| 2002-12-31 | $83.90 Million | -12.42% |
| 2001-12-31 | $95.80 Million | +12.86% |
| 2000-12-31 | $84.88 Million | +9.53% |
| 1999-12-31 | $77.50 Million | +4.73% |
| 1998-12-31 | $74.00 Million | +10.61% |
| 1997-12-31 | $66.90 Million | +5.85% |
| 1996-12-31 | $63.20 Million | +52.29% |
| 1995-12-31 | $41.50 Million | +23.15% |
| 1994-12-31 | $33.70 Million | +16.61% |
| 1993-12-31 | $28.90 Million | +20.92% |
| 1992-12-31 | $23.90 Million | +21.94% |
| 1991-12-31 | $19.60 Million | +18.79% |
| 1990-12-31 | $16.50 Million | +14.58% |
| 1989-12-31 | $14.40 Million | +11.63% |
| 1988-12-31 | $12.90 Million | +35.79% |
| 1987-12-31 | $9.50 Million | +28.38% |
| 1986-12-31 | $7.40 Million | +4.23% |
| 1985-12-31 | $7.10 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Natures Sunshine Products Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1014.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $76.93 Million | 47.62% |
| Common Stock | $102.19 Million | 63.26% |
| Other Comprehensive Income | $-17.57 Million | -10.87% |
| Total Equity | $161.55 Million | 100.00% |
Natures Sunshine Products Inc Competitors by Market Cap
The table below lists competitors of Natures Sunshine Products Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shenzhen Glory Medical Co Ltd
SHE:002551
|
$347.66 Million |
|
Globe Trade Centre S.A.
WAR:GTC
|
$347.70 Million |
|
VTEX
NYSE:VTEX
|
$347.86 Million |
|
FibraHotel
MX:FIHO12
|
$347.90 Million |
|
Unimot S.A
WAR:UNT
|
$347.45 Million |
|
Lim Seong Hai Capital Berhad
KLSE:0351
|
$347.30 Million |
|
Founders Metals Inc.
V:FDR
|
$347.23 Million |
|
VRG SA
WAR:VRG
|
$347.15 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Natures Sunshine Products Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 155,313,000 to 161,553,000, a change of 6,240,000 (4.0%).
- Net income of 19,521,000 contributed positively to equity growth.
- Share repurchases of 16,309,000 reduced equity.
- Other comprehensive income decreased equity by 896,000.
- Other factors increased equity by 3,924,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $19.52 Million | +12.08% |
| Share Repurchases | $16.31 Million | -10.1% |
| Other Comprehensive Income | $-896.00K | -0.55% |
| Other Changes | $3.92 Million | +2.43% |
| Total Change | $- | 4.02% |
Book Value vs Market Value Analysis
This analysis compares Natures Sunshine Products Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.30x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 50.97x to 2.30x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-12-31 | $0.39 | $20.08 | x |
| 1986-12-31 | $0.46 | $20.08 | x |
| 1987-12-31 | $0.62 | $20.08 | x |
| 1988-12-31 | $0.66 | $20.08 | x |
| 1989-12-31 | $0.76 | $20.08 | x |
| 1990-12-31 | $0.87 | $20.08 | x |
| 1991-12-31 | $1.07 | $20.08 | x |
| 1992-12-31 | $1.30 | $20.08 | x |
| 1993-12-31 | $1.54 | $20.08 | x |
| 1994-12-31 | $1.77 | $20.08 | x |
| 1995-12-31 | $2.20 | $20.08 | x |
| 1996-12-31 | $3.21 | $20.08 | x |
| 1997-12-31 | $3.53 | $20.08 | x |
| 1998-12-31 | $3.97 | $20.08 | x |
| 1999-12-31 | $4.35 | $20.08 | x |
| 2000-12-31 | $5.05 | $20.08 | x |
| 2001-12-31 | $5.69 | $20.08 | x |
| 2002-12-31 | $5.11 | $20.08 | x |
| 2003-12-31 | $5.46 | $20.08 | x |
| 2004-12-31 | $5.89 | $20.08 | x |
| 2005-12-31 | $4.86 | $20.08 | x |
| 2006-12-31 | $4.44 | $20.08 | x |
| 2007-12-31 | $3.90 | $20.08 | x |
| 2008-12-31 | $3.46 | $20.08 | x |
| 2009-12-31 | $3.68 | $20.08 | x |
| 2010-12-31 | $4.38 | $20.08 | x |
| 2011-12-31 | $5.57 | $20.08 | x |
| 2012-12-31 | $7.23 | $20.08 | x |
| 2013-12-31 | $6.42 | $20.08 | x |
| 2014-12-31 | $7.10 | $20.08 | x |
| 2015-12-31 | $6.96 | $20.08 | x |
| 2016-12-31 | $6.88 | $20.08 | x |
| 2017-12-31 | $6.32 | $20.08 | x |
| 2018-12-31 | $6.30 | $20.08 | x |
| 2019-12-31 | $6.57 | $20.08 | x |
| 2020-12-31 | $7.78 | $20.08 | x |
| 2021-12-31 | $7.78 | $20.08 | x |
| 2022-12-31 | $7.39 | $20.08 | x |
| 2023-12-31 | $7.91 | $20.08 | x |
| 2024-12-31 | $8.34 | $20.08 | x |
| 2025-12-31 | $8.75 | $20.08 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Natures Sunshine Products Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.08%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.07%
- • Asset Turnover: 1.84x
- • Equity Multiplier: 1.62x
- Recent ROE (12.08%) is below the historical average (13.28%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | 4.23% | 1.02% | 2.63x | 1.58x | $-410.00K |
| 1986 | 10.81% | 2.57% | 2.66x | 1.58x | $60.00K |
| 1987 | 21.05% | 5.24% | 2.62x | 1.54x | $1.05 Million |
| 1988 | 25.58% | 7.42% | 2.54x | 1.36x | $2.01 Million |
| 1989 | 27.78% | 7.68% | 2.59x | 1.40x | $2.56 Million |
| 1990 | 21.82% | 5.99% | 2.73x | 1.33x | $1.95 Million |
| 1991 | 23.47% | 6.34% | 2.65x | 1.40x | $2.64 Million |
| 1992 | 24.69% | 5.84% | 2.97x | 1.42x | $3.51 Million |
| 1993 | 26.04% | 5.90% | 3.07x | 1.44x | $4.62 Million |
| 1994 | 25.23% | 5.22% | 3.06x | 1.58x | $5.07 Million |
| 1995 | 28.67% | 5.79% | 3.15x | 1.57x | $7.75 Million |
| 1996 | 26.58% | 6.75% | 2.71x | 1.46x | $10.48 Million |
| 1997 | 30.04% | 7.16% | 2.93x | 1.43x | $13.41 Million |
| 1998 | 31.49% | 7.87% | 2.86x | 1.40x | $15.90 Million |
| 1999 | 22.97% | 6.15% | 2.69x | 1.39x | $10.05 Million |
| 2000 | 20.18% | 5.44% | 2.66x | 1.40x | $8.64 Million |
| 2001 | 17.39% | 5.23% | 2.43x | 1.37x | $7.08 Million |
| 2002 | 8.42% | 2.36% | 2.45x | 1.45x | $-1.33 Million |
| 2003 | 6.59% | 1.72% | 2.37x | 1.62x | $-2.64 Million |
| 2004 | 18.72% | 5.16% | 2.28x | 1.59x | $7.96 Million |
| 2005 | 4.65% | 1.00% | 2.39x | 1.95x | $-4.04 Million |
| 2006 | -5.23% | -0.98% | 2.44x | 2.18x | $-10.38 Million |
| 2007 | -13.64% | -2.25% | 2.22x | 2.74x | $-14.28 Million |
| 2008 | -3.42% | -0.48% | 2.32x | 3.06x | $-7.21 Million |
| 2009 | 10.71% | 1.78% | 2.08x | 2.89x | $405.50K |
| 2010 | -1.80% | -0.35% | 2.20x | 2.33x | $-8.07 Million |
| 2011 | 20.13% | 4.79% | 2.09x | 2.01x | $8.86 Million |
| 2012 | 21.95% | 6.91% | 1.89x | 1.68x | $13.82 Million |
| 2013 | 16.73% | 4.66% | 1.89x | 1.90x | $7.08 Million |
| 2014 | 8.00% | 2.73% | 1.86x | 1.57x | $-2.50 Million |
| 2015 | 11.00% | 4.52% | 1.62x | 1.50x | $1.34 Million |
| 2016 | 1.63% | 0.63% | 1.66x | 1.57x | $-10.97 Million |
| 2017 | -10.85% | -3.78% | 1.75x | 1.64x | $-24.87 Million |
| 2018 | -0.71% | -0.23% | 1.89x | 1.60x | $-12.90 Million |
| 2019 | 5.24% | 1.87% | 1.70x | 1.65x | $-6.16 Million |
| 2020 | 13.73% | 5.54% | 1.54x | 1.61x | $5.80 Million |
| 2021 | 18.24% | 6.50% | 1.72x | 1.64x | $13.03 Million |
| 2022 | -0.27% | -0.09% | 1.84x | 1.61x | $-14.68 Million |
| 2023 | 9.79% | 3.39% | 1.78x | 1.62x | $-329.80K |
| 2024 | 4.96% | 1.69% | 1.89x | 1.55x | $-7.84 Million |
| 2025 | 12.08% | 4.07% | 1.84x | 1.62x | $3.37 Million |
Industry Comparison
This section compares Natures Sunshine Products Inc's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $121,177,784
- Average return on equity (ROE) among peers: -150.66%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Natures Sunshine Products Inc (NATR) | $166.92 Million | 4.23% | 0.57x | $347.48 Million |
| Above Food Ingredients Inc. Common Stock (ABVE) | $199.86 Million | -2.89% | 0.00x | $5.11 Million |
| Agape ATP Corporation Common Stock (ATPC) | $1.93 Million | -128.06% | 0.68x | $2.64 Million |
| B&G Foods Inc (BGS) | $174.63 Million | 10.21% | 3.85x | $313.60 Million |
| BioHarvest Sciences Inc. Common Stock (BHST) | $1.33 Million | -970.90% | 17.80x | $72.31 Million |
| BranchOut Food Inc. Common Stock (BOF) | $5.57 Million | -109.92% | 1.60x | $57.59 Million |
| Bellring Brands LLC (BRBR) | $-65.50 Million | 0.00% | 0.00x | $1.05 Billion |
| BRC Inc. (BRCC) | $49.50 Million | -5.96% | 3.59x | $152.11 Million |
| BRF SA ADR (BRFS) | $800.55 Million | -313.82% | 16.84x | $5.38 Billion |
| Bridgford Foods Corporation (BRID) | $44.60 Million | 14.80% | 0.47x | $61.63 Million |
| Borealis Foods Inc. (BRLS) | $-695.89K | 0.00% | 0.00x | $28.97 Million |
About Natures Sunshine Products Inc
Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and v… Read more